Want to see IN:VAISHALI full AI Analyst Report?
Total Valuation
Vaishali Pharma Ltd. has a market cap or net worth of ₹784.65M. The enterprise value is ₹973.18M.
Market Cap₹784.65M
Enterprise Value₹973.18M
Share Statistics
Vaishali Pharma Ltd. has 107,192,130 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding107,192,130
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Vaishali Pharma Ltd.’s return on equity (ROE) is 0.01 and return on invested capital (ROIC) is -0.34%.
Return on Equity (ROE)0.01
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)-0.34%
Return on Capital Employed (ROCE)>-0.01
Revenue Per Employee36.68M
Profits Per Employee302.70K
Employee Count27
Asset Turnover0.90
Inventory Turnover18.45
Valuation Ratios
The current PE Ratio of Vaishali Pharma Ltd. is 22.8. Vaishali Pharma Ltd.’s PEG ratio is -11.79.
PE Ratio22.8
PS Ratio0.17
PB Ratio0.26
Price to Fair Value0.26
Price to FCF-0.86
Price to Operating Cash Flow0.00
PEG Ratio-11.79
Income Statement
In the last 12 months, Vaishali Pharma Ltd. had revenue of 990.26M and earned 8.17M in profits. Earnings per share was 0.56.
Revenue990.26M
Gross Profit102.85M
Operating Income-3.97M
Pretax Income12.26M
Net Income8.17M
EBITDA32.95M
Earnings Per Share (EPS)0.56
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Vaishali Pharma Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.26
52-Week Price Change-36.05%
50-Day Moving Average7.39
200-Day Moving Average8.44
Relative Strength Index (RSI)50.84
Average Volume (3m)399.32K
Important Dates
Vaishali Pharma Ltd. upcoming earnings date is Aug 18, 2026, TBA (Confirmed).
Last Earnings DateMay 30, 2026
Next Earnings DateAug 18, 2026
Ex-Dividend Date―
Financial Position
Vaishali Pharma Ltd. as a current ratio of 2.61, with Debt / Equity ratio of 27.33%
Current Ratio2.61
Quick Ratio2.49
Debt to Market Cap0.70
Net Debt to EBITDA3.25
Interest Coverage Ratio-0.25
Taxes
In the past 12 months, Vaishali Pharma Ltd. has paid 4.08M in taxes.
Income Tax4.08M
Effective Tax Rate0.33
Enterprise Valuation
Vaishali Pharma Ltd. EV to EBITDA ratio is 8.42, with an EV/FCF ratio of -1.41.
EV to Sales0.28
EV to EBITDA8.42
EV to Free Cash Flow-1.41
EV to Operating Cash Flow-1.43
Balance Sheet
Vaishali Pharma Ltd. has ₹10.46M in cash and marketable securities with ₹156.01M in debt, giving a net cash position of -₹145.55M billion.
Cash & Marketable Securities₹10.46M
Total Debt₹156.01M
Net Cash-₹145.55M
Net Cash Per Share-₹1.36
Tangible Book Value Per Share₹43.47
Margins
Gross margin is 10.17%, with operating margin of -0.40%, and net profit margin of 0.83%.
Gross Margin10.17%
Operating Margin-0.40%
Pretax Margin1.24%
Net Profit Margin0.83%
EBITDA Margin3.33%
EBIT Margin2.84%
Analyst Forecast
The average price target for Vaishali Pharma Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast9.84%
EPS Growth Forecast338.36%